A director at Infineon Technologies AG bought 10,000 shares at 30.500EUR and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
We maintain our Outperform rating on CaixaBank, one of our Top Picks in the sector, with a higher target of € 7.2 vs € 6.7 and ahead of the CMD on 19 November. We are lifting our net income estimates by 7% for 2025-2026, to 7% above the consensus. The strategic update is set to highlight the wisdom of the business model diversification (long-term savings) to address the current transition phase on rates. Despite a solid market performance, the profile does not look to be fully reflec...
Nous réitérons notre opinion Surperformance sur CaixaBank, l’un de nos top picks du secteur, avec un OC porté à 7.2 € vs 6.7 € et en amont du CMD du 19/11. Nous relevons nos anticipations de RN de 7% sur 2025/2026 qui ressortent 7% supérieures au consensus. L’update stratégique devrait mettre en avant la pertinence de la diversification du business model (épargne LT) face à la transition actuelle sur les taux. Malgré un solide parcours boursier, cela n’est pas pleinement reflété dans ...
>Outperform rating reiterated, despite the very cautious guidance for 2025, target price of € 36 vs € 38 - In the light of Q4 20245 results > forecasts (First take) and despite the guidance for Q1 2025 and 2025 below the lowest expectations of the consensus (including our assumption for zero growth), the share rapidly rebounded during the conference call (+3.5% at close). The idea that emerged from this publication is that the group has, this time, probably been suff...
>Opinion Surperformance réitérée, malgré les guidances très prudentes pour 2025, OC révisé à 36 € vs38 € - Suite à des résultats T4 24 > aux attentes (First take) et malgré des guidances T1 25 et 2025 inférieures aux attentes les plus basses du consensus (y compris la nôtre avec l’hypothèse d’une croissance zéro), le titre a rapidement rebondi durant la conférence call (+3,5% en clôture). L’idée qui ressort de cette publication est que le groupe a, cette fois-ci, pro...
>Q4 2024 results above expectations, despite lower sales - Infineon has reported its Q4 2024 results that beat expectations. Revenues were € 3.92bn, below the Vara Research consensus at € 3.97bn (vs guidance at € 4bn). The adjusted gross margin stood at 42.2%, above the consensus of 41.1%. Segment results were at € 832m i.e. a margin of 21.2%, above the consensus at € 788m and 19.9% (vs guidance for around 20%). Adjusted EPS was € 0.49 above consensus at € 0.46. This...
>Q4 2024 results above expectations, despite lower sales - Infineon has reported its Q4 2024 results that beat expectations. Revenues were € 3.92bn, below the Vara Research consensus at € 3.97bn (vs guidance at € 4bn). The adjusted gross margin stood at 42.2%, above the consensus of 41.1%. Segment results were at € 832m i.e. a margin of 21.2%, above the consensus at € 788m and 19.9% (vs guidance for around 20%). Adjusted EPS was € 0.49 above consensus at € 0.46. This...
EQS-News: Infineon Technologies AG / Key word(s): Quarterly / Interim Statement/Forecast Infineon concludes FY 2024 with an increase in revenue and earnings in the last quarter. FY 2025: Muted expectations in a weak market environment 12.11.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Q4 FY 2024: Revenue €3.919 billion, Segment Result €832 million, Segment Result Margin 21.2 percent FY 2024: Revenue €14.955 billion, down 8 percent on the prior year; Segment Result €3.105 billion; Segment Result Margin 20.8 percent; adjus...
EQS-News: Infineon Technologies AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Prognose Infineon schließt GJ 2024 mit Umsatz- und Ergebnisanstieg im letzten Quartal ab. GJ 2025: Gedämpfte Erwartungen in schwachem Marktumfeld 12.11.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Q4 GJ 2024: Umsatz 3,919 Milliarden Euro, Segmentergebnis 832 Millionen Euro, Segmentergebnis-Marge 21,2 Prozent GJ 2024: Umsatz 14,955 Milliarden Euro, minus 8 Prozent gegenüber Vorjahr, Segmentergebnis 3,105 Milliarden Euro, Segmentergebnis...
In this report we evaluate spreads in the TMT hybrids space. Over the year, TMT hybrid notes have performed well. However, we now think the tightening potential over senior notes is more limited. One can move up in quality (or lower duration) without giving up much additional spread.
Last week, we organised an Expert Access event on multiple sclerosis (MS) with the participation of Dr Géraldine Androdias, a neurologist at Lyon University Hospital. Dr Androdias presented the key points of the ECTRIMS 2024 conference, as well as new trends in treating the illness. We note an unmet need in the primary progressive and secondary progressive forms, a real interest for the BTKi class with the greater penetration of the blood-brain barrier, and expectations for the anti-C...
Nous avons organisé la semaine dernière un Expert Access autour de la sclérose en plaques (SEP) avec la participation du Dr Géraldine Androdias, médecin neurologue au CHU de Lyon. Le Dr Androdias a présenté les points saillants du congrès de l’ECTRIMS 2024 ainsi que les nouvelles tendances dans la prise en charge de la maladie. Nous retenons un besoin insatisfait dans les formes progressives et secondairement progressives, un vrai intérêt de la classe des BTKi avec le passage accru de...
>Forecasts revised by 17%, target price of € 38 vs € 46, but Outperform reiterated - Infineon is due to publish its Q4 2024 results on 12 November. Judging by the recent newsflow, specifically the series of profit warnings from the automobile sector, we expect results to come in a shade below forecasts. However, the key point of this publication will be the guidance for 2025, which we think will be more cautious than the average sell-side consensus. Indeed, we think ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.